Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

QUAVONLIMAB for Malignant melanoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 33 adverse event reports in the FDA FAERS database where QUAVONLIMAB was used for Malignant melanoma.

Most Reported Side Effects for QUAVONLIMAB

Side Effect Reports % Deaths Hosp.
Diarrhoea 26 7.1% 0 23
Anaemia 24 6.5% 1 23
Colitis 22 6.0% 0 21
Hyponatraemia 18 4.9% 2 18
Acute kidney injury 14 3.8% 0 14
Pneumonia 11 3.0% 0 11
Adrenal insufficiency 10 2.7% 1 10
Alanine aminotransferase increased 9 2.5% 1 9
Dehydration 9 2.5% 2 9
Hypertension 9 2.5% 0 7
Pyrexia 8 2.2% 0 8
Aspartate aminotransferase increased 7 1.9% 1 7
Dyspnoea 7 1.9% 0 7
General physical health deterioration 7 1.9% 0 7
Malignant neoplasm progression 7 1.9% 6 6

Other Indications for QUAVONLIMAB

Clear cell renal cell carcinoma (241) Renal cell carcinoma (32) Metastatic malignant melanoma (10) Hepatocellular carcinoma (9) Small cell lung cancer extensive stage (5)

Other Drugs Used for Malignant melanoma

NIVOLUMAB (10,599) IPILIMUMAB (8,903) DABRAFENIB (5,277) TRAMETINIB DIMETHYL SULFOXIDE (3,841) PEMBROLIZUMAB (3,261) BINIMETINIB (2,613) ENCORAFENIB (2,591) VEMURAFENIB (2,548) TRAMETINIB (1,448) COBIMETINIB (1,324)

Related Pages

QUAVONLIMAB Full Profile All Malignant melanoma Drugs QUAVONLIMAB Demographics QUAVONLIMAB Timeline